Health Care: Drugs

Mylan NV (MYL: NASDAQ)

$42.06 -0.53 | -1.24%
09/23/16 - 04:00 PM ET
Company Profile
Price and Volume
Recent Price 42.06
52 Week High 55.51
52 Week Low 37.59
Avg. Daily Vol. (Mil) 5.72
Beta (3 year) 1.46
Share Related Items
Mkt Cap (Mil) 22,498.38
Shares Out (Mil) 534.91
Float (Mil) 434.63
Dividend Information
Yield % 0.00
Annual Dividend 0.00
Payout Ratio 0.00
Financial Strength
Quick Ratio 1.00
Current Ratio 1.60
LT Debt/ Equity 0.64
Total Debt / Equity 0.76
Valuation Ratios
Price Earnings 24.70
Price/Sales 2.39
Price/Book 2.30
Price/Cash Flow 12.00
Per Share Data
Earnings 1.70
Sales 17.63
Book Value 18.25
Cash Flow 3.51
Business Summary
Mylan NV along with its subsidiaries is a pharmaceutical company. The Company develops, licenses, manufactures, markets and distributes generic, branded generic and specialty pharmaceuticals.
General Information
Building 4, Trident Place
Mosquito Way
Herts, AL10 9UL
www.mylan.com
Industry : Drugs
Sector: Health Care
Employees: 35000
CEO: Heather Bresch
Short Interest
Current Month (Mil) 21.51
Previous Month (Mil) 21.75
Short Interest Ratio (Days) 3.00
Management Effectiveness
Return on Equity 8.70
Return on Assets 3.80
Return on Investments 5.30
Profitability
Gross Margin 55.70
EBIT Margin 13.30
Profit Margin 9.00

Portfolios with MYL

Latest MYL Headlines from TheStreet

More Financial News for MYL

Press Releases for MYL

See All Press Releases
brokerage partners
connect with Stockpickr
Fan us on FaceBook
Follow us on Twitter